The role of ELF3 in acquired resistance to endocrine therapy in ER-positive breast cancer

被引：0
|
作者：
Zhang, Na
Zheng, Rongbin
Brown, Myles
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3894
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3894
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Late recurrence in ER-positive breast cancer
    Gralow, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [42] Tackling endocrine resistance in ER-positive HER2-negative advanced breast cancer: A tale of imprecision medicine
    Matikas, Alexios
    Foukakis, Theodoros
    Bergh, Jonas
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 114 : 91 - 101
  • [43] ERβ overexpression results in endocrine therapy resistance and poor prognosis in postmenopausal ERα-positive breast cancer patients
    Guo, Liying
    Zhang, Yu
    Yilamu, Dilimina
    Liu, Sha
    Guo, Chenming
    ONCOLOGY LETTERS, 2016, 11 (02) : 1531 - 1536
  • [44] Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy
    Larsen, Mathilde S.
    Bjerre, Karsten
    Lykkesfeldt, Anne E.
    Giobbie-Hurder, Anita
    Laenkholm, Anne-Vibeke
    Henriksen, Katrine L.
    Ejlertsen, Bent
    Rasmussen, Birgitte B.
    BREAST, 2012, 21 (05): : 662 - 668
  • [45] Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer
    da Silva, Leonardo Roberto
    de Andrade, Camila Annicchino
    Brenelli, Fabricio
    Ramalho, Susana
    Reinert, Tomas
    de Souza, Alessandra Borba Anton
    da Silva, Ana Elisa Ribeiro
    de Paula Leite Kraft, Maria Beatriz
    de Vasconcelos, Vivian Castro Antunes
    Frasson, Antonio Luiz
    Torresan, Renato Zochio
    Cabello, Cesar
    Ellis, Matthew J.
    Zeferino, Luiz Carlos
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 753 - 760
  • [46] Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer
    Leonardo Roberto da Silva
    Camila Annicchino de Andrade
    Fabrício Brenelli
    Susana Ramalho
    Tomás Reinert
    Alessandra Borba Anton de Souza
    Ana Elisa Ribeiro da Silva
    Maria Beatriz de Paula Leite Kraft
    Vivian Castro Antunes de Vasconcelos
    Antônio Luiz Frasson
    Renato Zochio Torresan
    Cesar Cabello
    Matthew J. Ellis
    Luiz Carlos Zeferino
    Breast Cancer Research and Treatment, 2021, 186 : 753 - 760
  • [47] A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy
    Tang, Jianing
    Cui, Qiuxia
    Zhang, Dan
    Kong, Deguang
    Liao, Xing
    Ren, Jiangbo
    Gong, Yan
    Wu, Gaosong
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (05) : 4746 - 4755
  • [48] Identification of preclinical mechanisms driving acquired resistance to endocrine therapy in estrogen-receptor positive (ER plus ) breast cancer cells
    Ong, C.
    Daemen, A.
    Merrick, K.
    O'Brien, T.
    Friedman, L.
    Hatzivassiliou, G.
    CANCER RESEARCH, 2019, 79 (04)
  • [49] Direct comparison of primary (neoadjuvant) endocrine therapy vs primary chemotherapy in postmenopausal women with ER-positive breast cancer
    不详
    BREAST, 2005, 14 : S39 - S39
  • [50] Histologic and Immunohistochemical Assessment of Early Stage, ER-Positive Breast Cancer Following Pre-Operative Endocrine Therapy
    Crawford, Michael
    Meneveau, Max
    Millard, Trish
    Showalter, Shayna
    Atkins, Kristen
    LABORATORY INVESTIGATION, 2023, 103 (03) : S121 - S122
12345